IPOs next week: Two mainboard, 3 SME public issues to keep primary market busy
Ratan Tata, Nikhil Kamath-backed BlueStone Jewellery plans ₹2,000 crore IPO: Report “Rise of the domestic capital, flourishing Indian entrepreneurship, improving governance, diligent institutional investors are among reasons likely to keep the IPO market ticking in 2024," Lunawat said. During the past week, two mainboard IPOs, namely Vibhor Steel Tubes and Entero Healthcare Solutions, commenced their offerings with the objective of raising a total of ₹1,672 crore. Entero experienced a lackluster debut on Friday as it entered the stock exchanges, contrasting with the anticipation surrounding Vibhor Steel Tubes' impending listing next week.
Alongside Vibhor Steel, six additional companies, including SMEs, are poised to introduce their shares to the exchanges. Also read: OTT platform Ullu Digital files DRHP with SEBI to raise funds via IPO; to list on BSE SME Looking ahead to the upcoming week, investors can expect mainboard IPOs from Juniper Hotels and GPT Healthcare, aiming to raise over ₹2,000 crore collectively. Concurrently, SME firms Zenith Drugs and Dream Roll Tech are also preparing to launch their respective issues, contributing to the dynamic activity in the market.
Juniper Hotels IPO opens for subscription on February 21, 2024 and closes on February 23, 2024. The mainboard IPO is a book built issue of ₹1,800 crores and is entirely a fresh issue of 5 crore shares. Juniper Hotels IPO price band is set at ₹342 to ₹360 per share.
Jm Financial Limited, Clsa India Private Limited and ICICI Securities Limited are the book running lead managers of the Juniper Hotels IPO, while Kfin Technologies Limited is the registrar for the issue. Also read: Juniper Hotels IPO opens next week. GMP, price, other details of upcoming IPO
. Read more on livemint.com
